APSR2026-548

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-009
P64
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220851-46904-APSR 2026_Poster_H.Shikanai_433666.pdf
Format: PDF Only
06. Tuberculosis
11

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Hisataka Shikanai * Hirosaki University Respiratory Medicine Hirosaki Japan
Tomonori Makiguchi - Hirosaki University Respiratory Medicine Hirosaki Japan
Yurika Inamura - Hirosaki University Student Hirosaki Japan
Yuri Takeuchi - Hirosaki University Respiratory Medicine Hirosaki Japan
Shunsuke Chiba - Hirosaki University Respiratory Medicine Hirosaki Japan
Shunta Mukai - Hirosaki University Respiratory Medicine Hirosaki Japan
Takashi Fukushima - Hirosaki University Respiratory Medicine Hirosaki Japan
Masamichi Itoga - Hirosaki University Respiratory Medicine Hirosaki Japan
Hisashi Tanaka - Hirosaki University Respiratory Medicine Hirosaki Japan
Kageaki Taima - Hirosaki University Respiratory Medicine Hirosaki Japan
Sadatomo Tasaka - Hirosaki University Respiratory Medicine Hirosaki Japan
 
 
 
 
Presenting Author Details
Hisataka
Shikanai
shikahisa1021@gmail.com
+819075611601
Under 30
Japan
Original Research
The relationship between sarcopenia and disease activity of Mycobacterium avium complex pulmonary diseases
Maximum 25 words
Abstract Content
Non-tuberculous mycobacterial (NTM) disease has been increasing worldwide. Body mass index, an index of nutrition status, is associated with disease progress. Recently, sarcopenia, which is characterized by reduced skeletal muscle mass and physical inactivity, affects the prognoses in a variety of diseases. We aimed to elucidate the impact of sarcopenia on the disease activity of Mycobacterium avium complex pulmonary diseases (MAC-PD) using CT images at diagnosis.
We included the patients diagnosed with MAC-PD from 2016 to 2019 at Hirosaki University Hospital. Diagnostic criteria as follows. i) CT images are consistent with NTM. ⅱ) positive PCR or culture at least twice in sputum, or once in bronchoalveolar fluid. Disease activity was evaluated by presence of cavity, number of lung segments involved, and sputum positivity, which includes either culture or PCR. Skeletal muscle mass index (SMI) is defined as skeletal muscle cross-sectional area (cm2) at carina level divided by height squared (m2). The lowest quartile of SMI in the entire population was defined as sarcopenia group (SG), and the other was non-sarcopenia group (NSG). Disease activity was compared between the two groups.
A total of 102 patients were included. The median value of age and SMI were 75 years old (range 51-94 years) and 18.8 cm2/m2 (range 11.1-30.1). Male accounted for 28.4%. The cutoff value of SMI was 17.1 cm2/m2. Non-cavitary bronchiectatic, cavitary nodular bronchiectatic and fibrocavitary form constitute 79.4, 17.6, and 3.0%, respectively. SMI was negatively correlated with lung segment number (rs=-0.24, p=0.02). Sputum positivity rate in SG and NSG were 57.7 and 32.9%, respectively (p=0.04). Cavity was observed in 26.9 and 18.4% in SG and NSG, respectively (p=0.40).
Sarcopenia might affect the disease activity in MAC-PD. Because this is a small-sized study, further research is needed.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
sarcopenia, disease activity, Mycobacterium avium complex
maximum 3 keywords and no abbreviations, separated by commas
None.
307